These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36436876)

  • 1. Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease.
    Mizuno T; Hoshino T; Ishizuka K; Toi S; Takahashi S; Wako S; Arai S; Kitagawa K
    J Atheroscler Thromb; 2023 Sep; 30(9):1198-1209. PubMed ID: 36436876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low estimated glomerular filtration rate explains the association between hyperhomocysteinemia and in-hospital mortality among patients with ischemic stroke/transient ischemic attack or intracerebral hemorrhage: Results from the Chinese Stroke Center Alliance.
    Liu W; Ma XL; Gu HQ; Li H; Li ZX; Wang YJ
    Int J Stroke; 2023 Mar; 18(3):354-363. PubMed ID: 35672911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hyperhomocysteinemia and stroke with atherosclerosis and small artery occlusion depends on homocysteine metabolism-related vitamin levels in Chinese patients with normal renal function.
    Wu GH; Kong FZ; Dong XF; Wu DF; Guo QZ; Shen AR; Cheng QZ; Luo WF
    Metab Brain Dis; 2017 Jun; 32(3):859-865. PubMed ID: 28261756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
    Ye Z; Zhang Q; Li Y; Wang C; Zhang J; Ma X; Peng H; Lou T
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27775590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Hyperhomocysteinemia with Stroke Recurrence after Initial Stroke.
    Kumral E; Saruhan G; Aktert D; Orman M
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2047-54. PubMed ID: 27260368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack.
    Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Takahashi S; Wako S; Kitagawa K
    Stroke; 2022 Jan; 53(1):79-86. PubMed ID: 34470483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study.
    Hoshino T; Mizuno T; Ishizuka K; Takahashi S; Arai S; Toi S; Kitagawa K
    Cardiovasc Diabetol; 2022 Nov; 21(1):264. PubMed ID: 36451149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiological Subtypes of Transient Ischemic Attack and Ischemic Stroke in Chronic Kidney Disease: Population-Based Study.
    Kelly DM; Li L; Rothwell PM;
    Stroke; 2020 Sep; 51(9):2786-2794. PubMed ID: 32811384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study.
    Shen Z; Zhang Z; Zhao W
    BMC Nephrol; 2022 Dec; 23(1):419. PubMed ID: 36587192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia Concurrent with Metabolic Syndrome Is Independently Associated with Chronic Kidney Disease among Community-Dwelling Adults in an Urban Korean Population.
    Moon H; Ko HJ; Kim AS
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32961936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study.
    Sun J; Han W; Wu S; Jia S; Yan Z; Guo Y; Zhao Y; Zhou Y; Liu X
    BMC Cardiovasc Disord; 2021 Oct; 21(1):484. PubMed ID: 34627150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D; Lancaster RT; Ergul E; Bertges D; Goodney P; Schermerhorn ML; Cambria RP; Patel VI;
    J Vasc Surg; 2016 Nov; 64(5):1295-1302. PubMed ID: 27776697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort.
    Kong X; Ma X; Zhang C; Su H; Xu D
    Int Urol Nephrol; 2017 Apr; 49(4):661-667. PubMed ID: 27822673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine might increase the risk of recurrence in patients presenting with primary cerebral infarction.
    Anniwaer J; Liu MZ; Xue KD; Maimaiti A; Xiamixiding A
    Int J Neurosci; 2019 Jul; 129(7):654-659. PubMed ID: 30215548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
    Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Hyperhomocysteinemia Combined with Metabolic Syndrome and Higher Prevalence of Stroke in Chinese Adults Who Have Elevated Blood Pressure.
    Hu F; Yu S; Li J; Zhou W; Wang T; Huang X; Bao H; Cheng X
    Med Sci Monit; 2022 Jan; 28():e934100. PubMed ID: 35013090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
    Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
    Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia and mortality after coronary artery bypass grafting.
    Girelli D; Martinelli N; Olivieri O; Pizzolo F; Friso S; Faccini G; Bozzini C; Tenuti I; Lotto V; Villa G; Guarini P; Trabetti E; Pignatti PF; Mazzucco A; Corrocher R
    PLoS One; 2006 Dec; 1(1):e83. PubMed ID: 17183715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.